11 Interstitial Lung Disease Clinical Trials in Phoenix, AZ (2026)

Q: How do I join a clinical trial in Phoenix?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you.

Recruiting Interstitial Lung Disease Studies in Phoenix

NCT06525259Recruiting

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic ...

Phoenix, AZ3,600 participantsGeorge Washington University

View Study Details

NCT05943535Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period....

Phoenix, AZPHASE3698 participantsUnited Therapeutics

View Study Details

NCT07652658Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

This Phase IIb study aims to evaluate the efficacy, safety, and tolerability of 3 doses of AZD8965 treatment compared to placebo in participants with IPF, including those on antifibrotic therapy (nint...

Phoenix, AZPHASE2359 participantsAstraZeneca

View Study Details

NCT05877196Recruiting

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

The goal of this clinical trial is to test 6 months of aerobic exercise in older adults who are 65 years or older and have mild cognitive impairment (MCI) or probable/possible mild Alzheimer's Disease...

Phoenix, AZNA216 participantsArizona State University

View Study Details

NCT04040452Recruiting

Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

The proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the ...

Phoenix, AZPHASE4166 participantsPhoenix Children's Hospital

View Study Details

NCT07091864Recruiting

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

This clinical trial studies whether continuous glucose monitoring (CGM) can be used to help patients with glioblastoma manage their blood sugar (glucose) levels and improve survival. Glioblastoma is t...

Phoenix, AZNA116 participantsMayo Clinic

View Study Details

NCT06372249Recruiting

A Clinical Trial of Soluble Fiber for Asthma

Randomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants...

Phoenix, AZPHASE2105 participantsPhoenix Children's Hospital

View Study Details

NCT05999994Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under th...

Phoenix, AZPHASE2105 participantsEli Lilly and Company

View Study Details

NCT05432804Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

This phase I/II trial tests the safety, side effects and best dose of selinexor given in combination with the usual chemotherapy (temozolomide) and compares the effect of this combination therapy vers...

Phoenix, AZPHASE197 participantsNational Cancer Institute (NCI)

View Study Details

NCT06429124Recruiting

Time Restricted Eating in Alzheimer's Disease

This pilot and feasibility study will enable the research team to determine the feasibility of implementing a time-restricted eating regimen among adults with mild cognitive impairment (MCI) and the i...

Phoenix, AZNA30 participantsSt. Joseph's Hospital and Medical Center, Phoenix

View Study Details

NCT06734286Recruiting

Working Memory Training in Patients with Mild Cognitive Impairment

The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memor...

Phoenix, AZNA10 participantsSt. Joseph's Hospital and Medical Center, Phoenix

View Study Details

About Interstitial Lung Disease Clinical Trials in Phoenix

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 11 interstitial lung disease clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 5,502 participants. Research is being sponsored by George Washington University, United Therapeutics, AstraZeneca and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Phoenix — FAQ

Are there interstitial lung disease clinical trials in Phoenix?

Yes, there are 11 interstitial lung disease clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 11 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated October 19, 2026 from ClinicalTrials.gov